Abstract:Osteosarcoma (OS) is a primary malignant tumor that occurs in bone, and mainly affects children and adolescents. C-type lectin domain family 3 member A (CLEC3A) is a member of the C-type lectin superfamily, which regulates various biological functions of cells. The present study aimed to identify the effects and related mechanisms of CLEC3A in the proliferation and chemosensitivity of OS cells. The expression of CLEC3A in OS was analyzed using the Gene Expression Omnibus data profile GSE99671, and its expression in OS samples was verified using reverse transcription-quantitative PCR (RT-qPCR) and immunohistochemical staining. The relationship between the expression of CLEC3A and clinical traits in patients with OS was also analyzed, including age, tumor size, TNM stage and lymph node metastasis. Cell Counting Kit-8 assays, colony formation assays and cell cycle distribution analysis were used to determine the roles of CLEC3A in the proliferation and chemosensitivity of OS cells. Finally, RT-qPCR and western blotting were used to demonstrate the relationship between CLEC3A and the AKT1/mTOR/hypoxia-inducible factor 1-alpha (HIF1 alpha) pathway. Both the mRNA and protein expression levels of CLEC3A were increased in OS tissues compared with adjacent non-tumor tissues, and this was positively associated with TNM stage and lymph node metastasis. The genetic knockdown of CLEC3A with small interfering RNA decreased OS cell proliferation and colony formation, and induced G1 phase arrest, whereas the overexpression of CLEC3A increased OS cell proliferation and colony formation, and alleviated G1 phase arrest. The suppression of CLEC3A also promoted enhanced the chemosensitivity of OS cells to doxorubicin (DOX) and cisplatin (CDDP); it also inhibited the expression of AKT1, mTOR and HIF1 alpha, further to the nuclear localization of HIF1 alpha, and HIF1 alpha target gene expression levels, including VEGF, GLUT1 and MCL1 were also decreased. Furthermore, treatment with the AKT activator SC79 blocked the inhibitory effects of CLEC3A silencing in OS cells. In conclusion, these findings suggested that CLEC3A may function as an oncogene in OS, and that the suppression of CLEC3A may inhibit OS cell proliferation and promote chemosensitivity through the AKT1/mTOR/HIF1 alpha signaling pathway.

CEP55 Promotes the Proliferation and Invasion of Tumour Cells Via the AKT Signalling Pathway in Osteosarcoma

MCAM is Associated with Metastasis and Poor Prognosis in Osteosarcoma by Modulating Tumor Cell Migration

CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

Carboxypeptidase E-ΔN promotes migration, invasion and epithelial-mesenchymal transition of human osteosarcoma cell lines through the Wnt/β-catenin pathway.

Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma

CSN5 Controls the Growth of Osteosarcoma Via Modulating the EGFR/PI3K/Akt Axis.

CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification

The Role of CEP55 Expression in Tumor Immune Response and Prognosis of Patients with Non-small Cell Lung Cancer.

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

MicroRNA-876-5p Inhibits Cell Proliferation, Migration and Invasion by Targeting C-Met in Osteosarcoma.

CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway

Suppression of CLEC3A Inhibits Osteosarcoma Cell Proliferation and Promotes Their Chemosensitivity Through the AKT1/mTOR/HIF1α Signaling Pathway

CSE1L Interaction with MSH6 Promotes Osteosarcoma Progression and Predicts Poor Patient Survival

Effect of activation of the Akt/mTOR signaling pathway by EEF1A2 on the biological behavior of osteosarcoma

COL12A1 Promotes Osteosarcoma Progression via the FAK/PI3K/AKT/mTOR Pathway

Promotion of Proliferation and Inhibition of Apoptosis by Diacylglycerol Kinase Zeta, a Potential Oncogene of Osteosarcoma

High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.

Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma

Expression of CEP55 in human glioma and its effect on the proliferation and apoptosis of glioma cell line U251

Transcription Factor CEBPB Inhibits the Proliferation of Osteosarcoma by Regulating Downstream Target Gene CLEC5A